Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naıïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study
posted on 2021-01-28, 11:10authored byAdis journals on behalf of, Martin Pfohl, Jochen Seufert, Anja Borck, Peter Bramlage, Thorsten Siegmund
Article full
text
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).